114 related articles for article (PubMed ID: 10405828)
1. Establishment of a human fusion partner for making human T-T hybridomas which can grow in serum free medium.
Kawahara H; Maeda-Yamamoto M; Hakamata K
Hum Antibodies; 1999; 9(2):83-7. PubMed ID: 10405828
[TBL] [Abstract][Full Text] [Related]
2. New human fusion partners, ICLU-B, -T, -E for making human hybridomas derived from various immunological cells.
Kawahara H; Maeda-Yamamoto M; Suzuki M; Hakamata K
Hum Antibodies; 1999; 9(2):89-94. PubMed ID: 10405829
[TBL] [Abstract][Full Text] [Related]
3. Preferential generation of human T cell hybrids with a tetraploid fusion partner.
Berger AE; Kuentzel SL; Davidson SO
J Immunol; 1985 Sep; 135(3):1792-9. PubMed ID: 3874906
[TBL] [Abstract][Full Text] [Related]
4. Secretion of human monoclonal antibody after fusion of an immortal T cell line and lymphocytes from the peripheral blood of a patient with colon carcinoma.
Dillman SL; Aldenderfer P; Strelkauskas A
Hum Antibodies Hybridomas; 1994; 5(1-2):32-40. PubMed ID: 7858181
[TBL] [Abstract][Full Text] [Related]
5. Efficient electric field-induced generation of hybridomas from human B lymphocytes without prior activation in vitro.
Kwekkeboom J; de Groot C; Tager JM
Hum Antibodies Hybridomas; 1992 Jan; 3(1):48-53. PubMed ID: 1576322
[TBL] [Abstract][Full Text] [Related]
6. Immortalization of magnetically separated human lymphocytes by electrofusion.
Glaser RW; Volk HD; Liebenthal C; Jahn S; Grunow R
Hum Antibodies Hybridomas; 1990; 1(2):111-4. PubMed ID: 1715775
[TBL] [Abstract][Full Text] [Related]
7. HO-323, a human B-lymphoblastoid cell line useful for making human-human hybridomas.
Ohashi H; Hashizume S; Murakami H; Aihara K; Shinohara K; Omura H
Cell Biol Int Rep; 1986 Feb; 10(2):77-83. PubMed ID: 3485476
[TBL] [Abstract][Full Text] [Related]
8. T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
Chou YK; Culbertson N; Rich C; LaTocha D; Buenafe AC; Huan J; Link J; Wands JM; Born WK; Offner H; Bourdette DN; Burrows GG; Vandenbark AA
J Neurosci Res; 2004 Sep; 77(5):670-80. PubMed ID: 15352213
[TBL] [Abstract][Full Text] [Related]
9. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
[TBL] [Abstract][Full Text] [Related]
10. Efforts to produce human cytotoxic T-cell hybridomas by electrofusion and PEG fusion.
Gravekamp C; Santoli D; Vreugdenhil R; Collard JG; Bolhuis RL
Hybridoma; 1987 Apr; 6(2):121-33. PubMed ID: 3494659
[TBL] [Abstract][Full Text] [Related]
11. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
12. The WI-L2-729-HF2 human hybridoma system. Stable hybrids at high frequency.
Heitzmann JG; Cohn M
Mol Biol Med; 1983 Sep; 1(2):235-43. PubMed ID: 6334216
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
[TBL] [Abstract][Full Text] [Related]
14. The effect of insulin on human-mouse hybridoma formation.
Bartal AH; Feit C; Hirshaut Y
Biomed Pharmacother; 1987; 41(2):93-6. PubMed ID: 3300812
[TBL] [Abstract][Full Text] [Related]
15. Functional human T cell-B cell hybridomas established from fusion of normal T cells and an EBV-transformed B cell line.
Kimata H; Berenson J; Kagan J; Saxon A
Clin Immunol Immunopathol; 1990 Jan; 54(1):134-47. PubMed ID: 2152857
[TBL] [Abstract][Full Text] [Related]
16. Impact of cell culture media on the expansion efficiency and T-cell receptor Vbeta (TRBV) repertoire of in vitro expanded T cells using feeder cells.
Block A; Rohde M; Erben U; Hammer M; Hummel M; Blunert K; Schultheiss HP; Volk HD; Noutsias M
Med Sci Monit; 2008 May; 14(5):BR88-95. PubMed ID: 18443543
[TBL] [Abstract][Full Text] [Related]
17. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium.
Lang AB; Schürch U; Zimmermann F; Bruderer U
J Immunol Methods; 1992 Sep; 154(1):21-6. PubMed ID: 1401940
[TBL] [Abstract][Full Text] [Related]
18. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
[TBL] [Abstract][Full Text] [Related]
19. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes.
Kalantarov GF; Rudchenko SA; Lobel L; Trakht I
Hum Antibodies; 2002; 11(3):85-96. PubMed ID: 12454369
[TBL] [Abstract][Full Text] [Related]
20. Generation of somatic cell hybrids capable of proliferating and secreting human monoclonal antibody without any growth factor supplements.
Hagiwara H; Yuasa H
Hum Antibodies Hybridomas; 1993 Jan; 4(1):15-9. PubMed ID: 8431553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
